September 30，The Ministry of Human Resources and Social Security issued "2016 National Basic Medical Insurance、Work Injury Insurance and Maternity Insurance Drug Directory Adjustment Work Plan (Draft for Opinions) "openly solicited comments，The overall requirements for the adjustment of the new round of medical insurance directory: 1、Complete the adjustment of the medical insurance and drug catalog before the end of 2016; 2、Modification and improvement of basic medical insurance drug management methods，Gradually establish a standardized drug directory dynamic adjustment mechanism。

 

  ① New medicine with high clinical value、② Class B adjustment of local B、③ Medication of major illness treatment、Children's medication、Urgent rescue medicine、Special medication for occupational diseases will be the key point，more focused on the clinical value and clinical basis of drugs。

 

  October 12，The Department of Medical Insurance Department of the Ministry of Human Resources and Social Affairs on the directory adjustment plan (draft for comments)My stake betting app，Holding a symposium with production and circulation enterprises，Listen to the opinions and suggestions of all parties。

 

  According to the news, the meeting of the meeting is as follows:

 

  1、Relevant person in charge of the Department of Medical Insurance of the Ministry of Human Resources and Social Security briefly introduced the 2016 version of the directory adjustment plan:

 

  1、This directory adjustment is mainly to solve the problem of historical debt owed (7 years have not been adjusted)，According to clinical medication needs、Fund tolerance，Focus on new drugs listed after 2009。

 

  2、Directory adjustment will establish a dynamic adjustment mechanism，Clear adjustment period，1 year or 2 years or special adjustment，A absolutely adjustable situation will be adjusted for 7 years。Directory adjustment will be linkage with the approval of new drugs，Reduce the pressure of new drugs，Meet clinical needs。

 

  3、When choosing a catalog,，We must focus on the following situations:

 

  First，Make up (supplement clinical gap)，Guarantee can be available。In the discussion with the clinical system in the morning，Relevant personnel also proposed to be for children、Elderly and rare medical medication for supplement。

 

  Second，Select the best，Reflection of medication progress，Promoting the development of the industry。

 

  Third，Support innovation，It is necessary to have a positive role in promoting the progress of the pharmaceutical industry。

 

  Fourth，Promoting competition。Catalog access contains multiple similar competitive products，Promote its benign competition，Reform through payment，Come and regulate medical insurance medicine。

 

  4、Directory adjustment rules: Follow the existing laws and regulations，Learn from the previous directory adjustment experience，Adhere to the review of Sangong and experts。At the same time, we must improve the national drug negotiation mechanism，For the three varieties of the negotiations, the Stake Sports Bettingthree varieties are preferred to be included in the directory，but also get the consent of the expert。The Ministry of Human Resources and Social Security will establish a drug negotiation mechanism in 2017。

 

  Two enterprise representatives speak。The main suggestion is classified as follows:

 

  1、Definition of new medicine & rdquo; definition，Consider the variety after 2007。

 

  2、Drug evaluation indicators should be more clear: more provincial category B supplement refers to the addition of several provinces。Another，Given that the current urban and rural medical insurance overall planning is underway，For the varieties incorporated into the New Rural Cooperation Catalog, it should also be considered (the relevant person in charge of the Department of Medical Insurance Answer: The addition of the local directory is only one of the reference data for expert review，Not necessary conditions，Can the variety be included in the national directory，It must be evaluated by multiple indicators)。

 

  3、For varieties that are included in the relevant clinical guidelines of domestic and foreign clinical usage、Domestic independent innovation varieties give key considerations。

 

  4、Refer to the 2015 version of the Pharmacopoeia，Revised the dosage type regulations in the examples，Chewing tablets、Black tablets, etc. are incorporated into the oral constant release dosage。In clinical applications，Rules through bidding and differences，You can control the price of this type of dosage drug，Therefore, it will not cause great pressure to the medical insurance fund。

 

  5、If the injection of a variety in the catalog is already，It is recommended to automatically include the oral dosage type，so that oral preparations can be used to give priority clinically，Guaranteed medication safety。

 

  6、Chinese and Western medicine covered in the directory should be similar to，instead of the same increase，Otherwise, it will be contrary to the policy and policy of the country's revitalization of Chinese medicine。

 

  stake online sports betting7、All 520 basis drugs are included in the national medical insurance catalog category。

 

  8、Prescription drugs and OTC varieties、Make up standards to be consistent，Especially for the new dosage types of some OTC varieties, we must give it.，To meet clinical needs。

 

  8、Increase the proportion of ethnic medicine，Establishing a national drug review team at the same time，The identification of ethnic medicine is further clarified。

 

  9. Children's medication is listed separately.

 

  10、Compound drugs are included in the national directory，No longer for provinces to operate，in order to facilitate the development of medical treatment in the later period。

 

  11、The division of the review professional group is more refined，The classification of drugs in the directory must also be updated。It is recommended to put some R & D company personnel、Retail pharmacies are included in the directory review expert。

 

  12、In view of the limited professional level of medical institutions below，May not understand for certain new drugs，It is recommended to reduce the number of selection experts from medical institutions at this level，from not less than 30%to 20%，or in the selection option，Add & ldquo; Do not understand & rdquo;，If this option is checked，Then the vote does not do statistics。

 

  13、It is not recommended to cap for the number of supplements to the provinces，Each province adds supplements based on its actual situation。

 

  14、Announced the list of directory alternative drugs，Opportunities for communicating and appealing to the enterprise。

 

  15、The criteria for judging drugs should be clear，Explain which medicines can take the negotiating procedure。

 

  16、& ldquo; Support encouraging medical innovation & rdquo; described in the plan too simple，The recommended plan can clarify those categories of innovation belonging to the support class，If the special new drug creation special、National Science and Technology Progress Award, etc.，Make Stake Sports Bettingthe solution more operable。

 

  Summary of the relevant person in charge of the Department of Medical Insurance:

 

  Directory adjustment cannot be satisfied with all aspects，Suggestions of some enterprises with individual interests，Its personal exponents，But I also hope that companies can also understand the rules of administrative management，Consider the problem from the perspective of the industry。& ldquo; Fairness、Justice、Public & rdquo;，Otherwise, the work will not be able to perform。Directory adjustment should be perfected in the process，Can't pursue perfection。